Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582391 | SCV000687963 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001467990 | SCV001672025 | likely benign | BAP1-related tumor predisposition syndrome | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582391 | SCV002713199 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV001467990 | SCV005406338 | benign | BAP1-related tumor predisposition syndrome | 2024-07-17 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |